Skip to main content
. Author manuscript; available in PMC: 2020 Mar 4.
Published in final edited form as: J Geriatr Oncol. 2019 Dec 6;11(2):284–289. doi: 10.1016/j.jgo.2019.10.004

Table 2.

Associations between Potential Cognitive Impairment and Severe Chemotherapy Toxicity

Univariate Analysis Adjusted Analysis*

Severe Chemotherapy Toxicity OR (95% CI) p-value Severe Chemotherapy Toxicity OR (95% CI) p-value

No Yes No Yes

Overall

Cognition 0.007 0.08
 Normal 222 231 211 222
 Potential Impairment 96 154 1.54 (1.13–2.11) 92 144 1.35 (0.96–1.90)

By Race/ Ethnicity

White
 Normal Cognition 191 206 183 197
 Potential Impairment 80 118 1.37 (0.97–1.93) 0.08 79 111 1.24 (0.86–1.80) 0.25

Non-White
 Normal Cognition 31 25 28 25
 Potential Impairment 16 36 2.79 (1.27–6.15) 0.01 13 33 1.98 (0.76–5.17) 0.16

By Education Level

High School Education or Less
 Normal Cognition 75 78 72 77
 Potential Impairment 36 69 1.84 (1.10–3.08) 0.02 33 64 1.87 (1.06–3.29) 0.03

Greater than High School Education
 Normal Cognition 146 153 138 145
 Potential Impairment 60 85 1.35 (0.91–2.02) 0.14 59 80 1.13 (0.73–1.74) 0.58

Abbreviations: OR = odds ratio; CI = confidence interval

*

Adjusted for CARG Toxicity Risk group (low, middle, high), 34 patients excluded due to missing CARG Toxicity Risk score data